Key Dates

Related Announcements

• September 26 , 2023 - Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional) See NOFO PAR-23-309

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice informs potential applicants that the National Institute on Drug Abuse (NIDA) is participating, effective immediately, in the notice of funding opportunity (NOFO) PAR-23-309, "Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional). "

The following sections of PAR-23-309 are updated as follows, shown in bold italics

Part 1. Overview Information

Components of Participating Organizations

National Institute on Minority Health and Health Disparities (NIMHD)

National Eye Institute (NEI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Drug Abuse (NIDA)

National Institute on Deafness and Other Communication Disorders (NIDCD)

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute of Nursing Research (NINR)

National Cancer Institute (NCI)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Sexual and Gender Minority Research Office (SGMRO)

Office of Behavioral and Social Sciences Research (OBSSR)

Assistance Listing Number(s)

93.307, 93.173, 93.865, 93.286, 93.361, 93.867, 93.273, 93.866, 93.399, 93.846, 93.853, 93.279

Part 2. Full Text of Announcement

Section I. Notice of Funding Opportunity Description

The following content has been added:

National Institute on Drug Abuse (NIDA)

The mission of NIDA is to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health. NIDA is interested in supporting research relevant to advancing the understanding of the effects of substance use among people living with disabilities and experiencing health disparities. This includes the identification and development of innovative strategies, prevention, and intervention methods, as well as policy changes to reduce negative effects of substance use among this population, specifically among racial and ethnic minorities, sexual and gender minorities, and other underserved populations. Priority areas include but are not limited to research on the following:

• How limited accessibility impacts substance use treatment and services.
• What are the substance use risks and potential compounded health disparities of underserved populations living with disabilities?
• Using an intersectional lens to examine substance use risk and protective factors among underserved populations living with disabilities, including exploring the availability and use (or lack thereof) of prevention services.
• Implementation science and health systems research to understand the impact of accessibility on substance use prevention and treatment efforts.
• How limited accessibility and barriers to accessibility impact seeking out and use of prevention and treatment services (transportation, adequate parking at treatment facilities, SUD counseling that isn t adapted for people with cognitive disabilities, no materials in Braille or other alternative formats, lack of staff training on technologies for communicating with people who are deaf, etc.).
• What is the impact of stress among this population that can lead to substance use and/or addiction, and how can community services alleviate stress to facilitate the substance use intervention process?
• What is the impact of stigma against underserved populations living with disabilities and how that affects seeking and use of substance use prevention and treatment services?
• What gaps exist in medical and community settings that may prevent adequate addiction services for underserved populations living with disabilities?
• Evaluating financial issues that may stem from living with a disability and lead to substance use. How unemployment due to a disability impacts substance use. How do the combined costs of substance use services and accessibility accommodations impact the uptake and use of substance use services and outcomes?
• Development of substance use prevention and intervention strategies among underserved populations living with disabilities.

Section VII. Agency Contacts

The following contacts have been added:

Scientific/Research Contact(s)

Sheba K. Dunston, EdD
National Institute on Drug Abuse (NIDA)
Phone: 301-402-1526
Email: Sheba.Dunston@nih.gov

Financial/Grants Management Contact(s)

Christina Rinaldi
National Institute on Drug Abuse (NIDA)
Phone: 301-827-0937
Email: christina.rinaldi@nih.gov

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Sheba K. Dunston, EdD
National Institute on Drug Abuse (NIDA)
Phone: 301-402-1526
Email: Sheba.Dunston@nih.gov